These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 5179829)

  • 1. [Intensive studies with vasopressin lysine].
    Garrido Carmona E
    Rev Asoc Mex Enferm; 1966; 13(1):9-10. PubMed ID: 5179829
    [No Abstract]   [Full Text] [Related]  

  • 2. [Secondary diuresis following intravenous administration of phenylalanine-2-lysine-8-vasopressin in patients with liver cirrhosis].
    Gómez Mont F; Ramírez C; Perches A; Gómez Peralta L; Nava Lara L
    Gac Med Mex; 1967 Feb; 97(2):244-58. PubMed ID: 5612503
    [No Abstract]   [Full Text] [Related]  

  • 3. [Urinary excretion of magnesium in patients with liver cirrhosis treated with oral diuretics. Its variation through vasopressin].
    Bardi A; Merino I; Rendic Y; Generini G
    Rev Med Chil; 1968 Jun; 96(6):415-9. PubMed ID: 5730619
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lessons drawn from 25 years of vasopressin use in patients with cirrhosis].
    Barbare JC; Poupon R
    Gastroenterol Clin Biol; 1984 Mar; 8(3):253-4. PubMed ID: 6609097
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis.
    Ferguson JW; Therapondos G; Newby DE; Hayes PC
    Clin Sci (Lond); 2003 Jul; 105(1):1-8. PubMed ID: 12639215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of insipid pitressin-resistant polyuria in an edematous cirrhotic. Physiopathologic bases of polyuria of hydropigenous cirrhotics].
    Plauchu M; Berger G; Dazord A
    Lyon Med; 1969 Mar; 221(9):437-42. PubMed ID: 5360532
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyponatremia of cirrhosis: role of vasopressin and decreased 'effective' plasma volume.
    Akriviadis EA; Ervin MG; Cominelli F; Fisher DA; Reynolds TB
    Scand J Gastroenterol; 1997 Aug; 32(8):829-34. PubMed ID: 9282977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of hemorrhages from esophageal varices with a vasopressin derivative].
    Schröder P
    Med Welt; 1969 Feb; 8():436-7. PubMed ID: 5771344
    [No Abstract]   [Full Text] [Related]  

  • 9. [Aquaretic agents].
    Bosch-Marcé M; Clària J; Jiménez W
    Gastroenterol Hepatol; 1996 Nov; 19(9):472-7. PubMed ID: 8998673
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation and revision of a vasopressin/nitroglycerin protocol for use in variceal bleeding.
    Burns SM; Martin M; Merrill P; Luer J; Stone DD
    Am J Crit Care; 1993 May; 2(3):202-7. PubMed ID: 8364671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and efficacy of the use of vasopressin in sepsis and septic shock.
    Wilson SJ; Mehta SS; Bellamy MC
    Expert Opin Drug Saf; 2005 Nov; 4(6):1027-39. PubMed ID: 16255662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of portal circulation by the umbilical route: registration of pressure, humoral study and action of phenylalanine-lysine-vasopressin].
    Fernandez A; Callejas F; Basso AL; Cat M; Silva C; Sabini G; Piriz H
    Rev Int Hepatol; 1969; 19(7):509-27. PubMed ID: 5404764
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical need for antidiuretic hormone antagonists in cirrhosis.
    Arroyo V; Jiménez W
    Hepatology; 2003 Jan; 37(1):13-5. PubMed ID: 12500182
    [No Abstract]   [Full Text] [Related]  

  • 14. Vasopressin release, water channels, and vasopressin antagonism in cardiac failure, cirrhosis, and pregnancy.
    Schrier RW; Fassett RG; Ohara M; Martin PY
    Proc Assoc Am Physicians; 1998; 110(5):407-11. PubMed ID: 9756091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. THE EFFECTS OF SYNTHETIC VASOPRESSIN AND ANGIOTENSIN ON THE CIRCULATION IN CIRRHOSIS OF THE LIVER.
    SEGEL N; BAYLEY TJ; PATON A; DYKES PW; BISHOP JM
    Clin Sci; 1963 Aug; 25():43-55. PubMed ID: 14058242
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic and diagnostic potential of a vasopressin-2 antagonist for impaired water handling in cirrhosis.
    Inoue T; Ohnishi A; Matsuo A; Kawai B; Kunihiro N; Tada Y; Koizumi F; Chau T; Okada K; Yamamura Y; Tanaka T
    Clin Pharmacol Ther; 1998 May; 63(5):561-70. PubMed ID: 9630829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug treatment for portal hypertension due to cirrhosis].
    Lebrec D; Benhamou JP
    Gastroenterol Clin Biol; 1982; 6(6-7):542-8. PubMed ID: 6126417
    [No Abstract]   [Full Text] [Related]  

  • 18. [2-phenylalanine-8-lysine vasopressin as a vasoconstrictor agent in obstetrical wounds. (Episiotomy and perineal tears)].
    Segovia J; Flitas F
    Rev Obstet Ginecol Venez; 1966; 26(4):751-7. PubMed ID: 5989632
    [No Abstract]   [Full Text] [Related]  

  • 19. Vasopressin in the cardiac surgery intensive care unit.
    Albright TN; Zimmerman MA; Selzman CH
    Am J Crit Care; 2002 Jul; 11(4):326-30; quiz 331-2. PubMed ID: 12102433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin: applications in clinical practice.
    Dyke PC; Tobias JD
    J Intensive Care Med; 2004; 19(4):220-8. PubMed ID: 15296622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.